Bosh sahifaABUS • NASDAQ
add
Arbutus Biopharma Corp
3,08 $
Seans yopilganidan keyin:(0,00%)0,00
3,08 $
Yopilgan:16-may, 16:02:40 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
3,12 $
Kunlik diapazon
3,05 $ - 3,15 $
Yillik diapazon
2,71 $ - 4,72 $
Bozor kapitalizatsiyasi
589,90 mln USD
Oʻrtacha hajm
1,05 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,76 mln | 15,14% |
Joriy xarajat | 5,83 mln | 9,79% |
Sof foyda | -24,53 mln | -37,21% |
Sof foyda marjasi | -1,39 ming | -19,16% |
Har bir ulushga tushum | -0,18 | -32,01% |
EBITDA | -12,70 mln | 32,56% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 112,71 mln | -12,79% |
Jami aktivlari | 117,01 mln | -22,14% |
Jami passivlari | 37,85 mln | 6,17% |
Umumiy kapital | 79,16 mln | — |
Tarqatilgan aksiyalar | 191,53 mln | — |
Narxi/balansdagi bahosi | 7,61 | — |
Aktivlardan daromad | -26,19% | — |
Kapitaldan daromad | -34,60% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -24,53 mln | -37,21% |
Operatsiyalardan naqd pul | -13,39 mln | 30,60% |
Sarmoyadan naqd pul | 11,35 mln | -2,95% |
Moliyadan naqd pul | 2,78 mln | -88,60% |
Naqd pulning sof oʻzgarishi | 746,00 ming | -95,56% |
Boʻsh pul | 59,62 ming | 100,47% |
Haqida
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Tashkil etilgan
2007
Sayt
Xodimlar soni
44
